'Proactive' versus 'reactive' anti-VEGF therapies for neovascular age-related macular degeneration: pros and cons

被引：1
作者：
Yasukawa, Tsutomu [1 ]
机构：
[1] Nagoya City Univ, Grad Sch Med Sci, Dept Ophthalmol & Visual Sci, Mizuho Ku, 1 Kawasumi, Nagoya, Aichi 4678601, Japan
来源：
EXPERT REVIEW OF OPHTHALMOLOGY | 2013年 / 8卷 / 04期
关键词：
age-related macular degeneration; anti-VEGF therapy; individualized medicine; pro re nata;
D O I：
10.1586/17469899.2013.814960
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
[No abstract available]
引用
收藏
页码：321 / 326
页数：6
相关论文
共 36 条
[1]   Characterization of β amyloid assemblies in drusen:: the deposits associated with aging and age-related macular degeneration [J].
Anderson, DH ;
Talaga, KC ;
Rivest, AJ ;
Barron, E ;
Hageman, GS ;
Johnson, LV .
EXPERIMENTAL EYE RESEARCH, 2004, 78 (02) :243-256
[2]   Perspective - A role for local inflammation in the formation of drusen in the aging eye [J].
Anderson, DH ;
Mullins, RF ;
Hageman, GS ;
Johnson, LV .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2002, 134 (03) :411-431
[3]   AN INTERNATIONAL CLASSIFICATION AND GRADING SYSTEM FOR AGE-RELATED MACULOPATHY AND AGE-RELATED MACULAR DEGENERATION [J].
BIRD, AEC ;
BRESSLER, NM ;
BRESSLER, SB ;
CHISHOLM, IH ;
COSCAS, G ;
DAVIS, MD ;
DEJONG, PTVM ;
KLAVER, CCW ;
KLEIN, BEK ;
KLEIN, R ;
MITCHELL, P ;
SARKS, JP ;
SARKS, SH ;
SOURBANE, G ;
TAYLOR, HR ;
VINGERLING, JR .
SURVEY OF OPHTHALMOLOGY, 1995, 39 (05) :367-374
[4]   Evidence for an inflammatory process in age-related macular degeneration gains new support [J].
Bok, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (20) :7053-7054
[5]   CEREBROVASCULAR ACCIDENTS IN PATIENTS TREATED FOR CHOROIDAL NEOVASCULARIZATION WITH RANIBIZUMAB IN RANDOMIZED CONTROLLED TRIALS [J].
Bressler, Neil M. ;
Boyer, David S. ;
Williams, David F. ;
Butler, Steven ;
Francom, Steven F. ;
Brown, Benton ;
Di Nucci, Flavia ;
Cramm, Timothy ;
Tuomi, Lisa L. ;
Ianchulev, Tsontcho ;
Rubio, Roman G. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (09) :1821-1828
[6]   Ranibizumab versus verteporfin for neovascular age-related macular degeneration [J].
Brown, David M. ;
Kaiser, Peter K. ;
Michels, Mark ;
Soubrane, Gisele ;
Heier, Jeffrey S. ;
Kim, Robert Y. ;
Sy, Judy P. ;
Schneider, Susan .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1432-1444
[7]   Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration [J].
Busbee, Brandon G. ;
Ho, Allen C. ;
Brown, David M. ;
Heier, Jeffrey S. ;
Suner, Ivan J. ;
Li, Zhengrong ;
Rubio, Roman G. ;
Lai, Phillip .
OPHTHALMOLOGY, 2013, 120 (05) :1046-1056
[8]   Cigarette smoke-related oxidants and the development of sub-RPE deposits in an experimental animal model of dry AMD [J].
Espinosa-Heidmann, DG ;
Suner, IJ ;
Catanuto, P ;
Hernandez, EP ;
Marin-Castano, ME ;
Cousins, SW .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (02) :729-737
[9]   Advanced Glycation End Product (AGE) Accumulation on Bruch's Membrane: Links to Age-Related RPE Dysfunction [J].
Glenn, Josephine V. ;
Mahaffy, Helen ;
Wu, Keqiang ;
Smith, Gill ;
Nagai, Ryoji ;
Simpson, David A. C. ;
Boulton, Michael E. ;
Stitt, Alan W. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (01) :441-451
[10]   A Treat and Extend Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration Clinical and Economic Impact [J].
Gupta, Omesh P. ;
Shienbaum, Gary ;
Patel, Avni H. ;
Fecarotta, Christopher ;
Kaiser, Richard S. ;
Regillo, Carl D. .
OPHTHALMOLOGY, 2010, 117 (11) :2134-2140
1234